Chang Hoon Lee received his M.S. from Seoul National University in 2004 and received his Ph.D. from the University at Buffalo (The State University of New York) in 2011. In 2011, he was Post-doctoral research scientist at the National Institute of Health (Bethesda, MD, USA). Since 2011, he has been the Principal Investigator at the Korea Research Institute of Chemical Technology. His research interests mainly include EMT, keratin phosphorylation, serotonin receptor, antinociceptive, anti-itching, pro-resolving, yet another novel kinase, inflammation, cancer, metastasis, tumours, and chemokines.